Where does Emulate, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Emulate, Inc. ranks #4,557 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Emulate, Inc. hold?

Emulate, Inc. holds 77 US utility patents granted between 2017 and 2025, spanning 17 technology areas.

What is Emulate, Inc.'s Innovation Score?

Emulate, Inc. has an Innovation Score of 45.9 out of 100 (top 22% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Emulate, Inc.'s patent grant rate increasing or decreasing?

Emulate, Inc.'s recent grant velocity is +354% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Emulate, Inc.'s patents?

Emulate, Inc.'s patents average 16.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Emulate, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Emulate, Inc.

Q: What technology areas does Emulate, Inc. focus on?

Emulate, Inc.'s top technology area is C12M (Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters) with 61 patents, ranking #7 of 832 assignees active in that subclass. Grants appear in 17 CPC subclasses total.

USPTO PatentsView assignee record - 77 granted patents across 17 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12M (Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Ferme).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Emulate ranks #4,557 of 49,997 tracked US assignees by granted-patent volume, with 77 patents across 17 technology areas.

#4,557
of 49,997 US assignees by volume: Top 22%
by Innovation Score (45.9/100): 16.0
avg claims per patent: +354%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4557 · US Corporation #4,557 · 77 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 77 grants
TOP-DECILE #4,557/49,997
PHOTO-FINISH Cardiovascular Systems
CPC-FOCUS C12M · 17 areas
INNOV-PAR 45.9/100
CLAIMS-RICH 16.0 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +354% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Cardiovascular Systems, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Emulate’s 45.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 15.0 pts (33%) Velocity 6.7 pts (15%) Breadth 14.6 pts (32%) Claim depth 9.6 pts (21%)

Qualcomm Incorporated · highest

85
Arrcus · near

46
Danfoss Power… · near

46
Emulate · this assignee

46
Nissin Kogyo · near

46
Silego Technology · near

46
3D Lighting… · lowest

7

What this shows Emulate's Innovation Score is 45.9/100 (top 22% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Emulate?

Each dot is one of Emulate’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Emulate’s own 16.0 claims/patent is at or below the 16.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Emulate vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Emulate's grants concentrate

Emulate, Inc. is a focused PatentsView assignee: 17 CPC subclasses with 79.2% of grants classified under C12M (Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Ferme). Peak complete grant year is 2021 (17 grants) versus a trough of 1 in 2017. By volume, Emulate sits between Cardiovascular Systems, Inc. and Hangzhou Sanhua Research Institute Co., Ltd..

Emulate's three-year grant acceleration

From 2019–2021 to 2022–2024, Emulate, Inc. moved from 34 to 34 grants (1.00x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Cardiovascular Sy…

77
Credo Technology…

77
Dong-eui Universi…

77
Dril-quip

77
GAF Energy

77
GE Oil & Gas Pres…

77
GLO AB

77
Hangzhou Sanhua R…

77
Emulate ◀

77

What this shows Emulate holds 77 patents at rank #4,557, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Emulate

By rank, the assignees closest to #4,557 in granted patent volume.

Leaders in C12M (Apparatus FOR Enzymology OR Microbiology)

Other assignees with the most granted patents in Emulate's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Emulate, neither rank-band nor same-CPC leaders (those blocks stay above). In C12M (Apparatus FOR Enzymology OR Microbiology), Emulate ranks #7 of 832 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (46 here).

Danfoss Power Solutions APS 46 Nissin Kogyo Co., Ltd. 46 Arrcus Inc. 46 Silego Technology Inc. 46

Similar claim depth

Nearest assignees by average claims per patent (16.0 here).

O&M Halyard, Inc. 16.0 avg Diodes Incorporated 16.0 avg Multivac Sepp Haggenmüller Se & Co. KG 16.0 avg Massachusetts Eye and Ear Infirmary 16.0 avg

Emulate's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

46 Top 22% higher than 78% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Emulate, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	1.3%
2018	3	3.9%
2019	9	11.7%
2020	8	10.4%
2021	17	22.1%
2022	10	13.0%
2023	12	15.6%
2024	12	15.6%
2025partial year	5	6.5%

Which technologies does Emulate, Inc. patent most?

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 61

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 53

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 44

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 38

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 12

C07K - Peptides 9

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 7

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

B01D - Separation 2

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

G01T - Measurement OF Nuclear OR X-radiation 1

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 1

C08J - WORKING-UP; General Processes OF COMPOUNDING; After-treatment NOT Covered BY Subclasses C08b, C08c, C08f, C08g or C08h 1

Top 15 of 17 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Emulate, Inc.'s patent record in context - here's where to go next.

Emulate, Inc.'s lead technology class is C12M (Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Ferme), 79.2% of its portfolio - see every assignee active in that class. Explore C12M
Ranked #4,557 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Emulate, Inc. against Cardiovascular Systems, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 45.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.